Learn More
Invitrogen™ GSDMD Recombinant Rabbit Monoclonal Antibody (PD00-18)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA550686
Description
Positive control: PC-3 cell lysate, NIH/3T3 cell lysate, THP-1 cell lysate, THP-1 cell lysate treated with PMA for 17.5 hours and then treated with LPS for 6 hours, PC-12 cell lysate, PMVEC cell lysate, RH-35 cell lysate, L6 cell lysate. Predicted band size: 53/30 kDa Subcellular Location: Cell membrane, Secreted.
GSDMD (gasdermin-D) promotes pyroptosis in response to microbial infection and danger signals. It is produced by the cleavage of gasdermin-D by inflammatory caspases CASP1 or CASP4 in response to canonical, as well as, non-canonical (such as cytosolic LPS) inflammasome activators. After cleavage, GSDMD moves to the plasma membrane where it strongly binds to inner leaflet lipids including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-biphosphate, phosphatidylinositol (3,4,5)-biphosphate, phosphatidic acid, and phosphatidylserine. GSDMD also exhibits bactericidal activity.
Specifications
GSDMD | |
Recombinant Monoclonal | |
1 mg/mL | |
PBS with 0.1% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4 | |
P57764, Q9D8T2 | |
GSDMD | |
Recombinant protein within Gasdermin D full length protein aa 1-484/484. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Western Blot | |
PD00-18 | |
Unconjugated | |
GSDMD | |
1810036L03Rik; AW558049; DF5L; Dfna5l; FKSG10; gasdermin D; gasdermin domain containing 1; gasdermin domain-containing protein 1; Gasdermin-D; Gasdermin-D, C-terminal; Gasdermin-D, N-terminal; GSDMD; GSDMDC1; GSDMD-CT; GSDMD-NT; M2-4 | |
Rabbit | |
Protein A | |
RUO | |
315084, 69146, 79792 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.